VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+39.18%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$417M
AUM Growth
+$417M
Cap. Flow
+$21.8M
Cap. Flow %
5.22%
Top 10 Hldgs %
91.13%
Holding
24
New
3
Increased
5
Reduced
5
Closed
6

Top Buys

1
SVRA icon
Savara
SVRA
$18.7M
2
ANAB icon
AnaptysBio
ANAB
$11.6M
3
OBSV
ObsEva SA Ordinary Shares
OBSV
$5.73M
4
SPRO icon
Spero Therapeutics
SPRO
$5.71M
5
GYRE icon
Gyre Therapeutics
GYRE
$3.22M

Top Sells

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
$11.4M
2
ASND icon
Ascendis Pharma
ASND
$7.45M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
$3.36M
4
PDSB icon
PDS Biotechnology
PDSB
$2.85M
5
ZGNX
Zogenix, Inc.
ZGNX
$2.12M

Sector Composition

1 Healthcare 92.72%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$115M 27.47%
1,035,657
– –
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$46.4M 11.11%
1,718,605
+54,305
+3% +$1.47M
ASND icon
3
Ascendis Pharma
ASND
$11.8B
$44.6M 10.69%
1,113,014
-186,038
-14% -$7.45M
ARGX icon
4
argenx
ARGX
$43.6B
$41M 9.83%
649,665
+2,650
+0.4% +$167K
ZGNX
5
DELISTED
Zogenix, Inc.
ZGNX
$34.2M 8.2%
854,057
-53,000
-6% -$2.12M
ANAB icon
6
AnaptysBio
ANAB
$569M
$28.5M 6.82%
282,550
+115,000
+69% +$11.6M
OBSV
7
DELISTED
ObsEva SA Ordinary Shares
OBSV
$19.4M 4.65%
1,988,843
+587,500
+42% +$5.73M
SVRA icon
8
Savara
SVRA
$567M
$18.7M 4.48%
+1,259,500
New +$18.7M
BCRX icon
9
BioCryst Pharmaceuticals
BCRX
$1.74B
$12.2M 2.92%
2,482,119
-683,338
-22% -$3.36M
BLPH
10
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$9.67M 2.32%
4,149,378
– –
PDSB icon
11
PDS Biotechnology
PDSB
$57.8M
$9.14M 2.19%
975,103
-304,164
-24% -$2.85M
SPRO icon
12
Spero Therapeutics
SPRO
$116M
$5.71M 1.37%
+485,615
New +$5.71M
RARX
13
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$4.63M 1.11%
544,612
-225,159
-29% -$1.91M
GYRE icon
14
Gyre Therapeutics
GYRE
$703M
$3.22M 0.77%
+235,676
New +$3.22M
AKTX
15
Akari Therapeutics
AKTX
$24.8M
$1.85M 0.44%
426,297
– –
ORKA
16
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$1.46M 0.35%
1,078,932
– –
LPCN icon
17
Lipocine
LPCN
$15.8M
$1.33M 0.32%
386,928
– –
ADVM icon
18
Adverum Biotechnologies
ADVM
$64.6M
– –
-280,000
Closed -$1.02M
KALV icon
19
KalVista Pharmaceuticals
KALV
$678M
– –
-221,651
Closed -$1.49M
MDGL icon
20
Madrigal Pharmaceuticals
MDGL
$9.76B
– –
-30,000
Closed -$1.35M
SIOX
21
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
– –
-76,162
Closed -$524K
MYOK
22
DELISTED
MyoKardia, Inc. Common Stock
MYOK
– –
-265,000
Closed -$11.4M
OCRX
23
DELISTED
Ocera Therapeutics, Inc.
OCRX
– –
-477,269
Closed -$544K